← SynDRA
RG-4733
SynDRA canonical compound SYN0039576 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | NOTCH1 | PSEN1 |
|---|
| Mechanism of action | gamma secretase inhibitor |
|---|
All known targets
- APH1A
- APH1A; APH1B; NCSTN; PSENEN; PSEN1
- APH1B
- NCSTN
- PSEN1
- PSEN2
- PSENEN
Mechanisms of action (all sources)
- APH1A INHIBITOR
- gamma-secretase inhibitor
- PSENEN INHIBITOR
- APH1B INHIBITOR
- PSEN1 INHIBITOR
- NCSTN INHIBITOR
- PSEN2 INHIBITOR
- Modulator
Cross-references
Synonyms
- Ro4929097
- RO-4929097
- Ro 4929097
- RO4929097
- UNII-KK8645V7LE
- KK8645V7LE
- N1-[(7S)-6,7-dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide
- n1-((7s)-6,7-dihydro-6-oxo-5h-dibenz(b,d)azepin-7-yl)-2,2-dimethyl-n3-(2,2,3,3,3-pentafluoropropyl)propanediamide
- OJPLJFIFUQPSJR-INIZCTEOSA-N
- cc-19
- MLS006011071
- SCHEMBL1376366
- GTPL7338
- CHEBI:86474
- DTXSID20233833
- C22H20F5N3O3
- MolPort-016-633-243
- BCPP000088
- EX-A1750
- ZINC43208642
- ABP000966
- s1575
- AKOS027250816
- Rg 4733
- RefChem:179057
- RG4733
- Ro492097
- R-4733
- orb1300914
- SCHEMBL29353153
- RG 4733 [WHO-DD]
- GLXC-90468
- BDBM50533417
- NSC756650
- CS-0480
- FR65150
- NSC-756650
- NCGC00263162-01
Look up RG-4733 in the interactive SynDRA portal →